LEILY SANTOS-CARRION: Open Payments
NPI 1164098257 · MIAMI BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,349 in 129 payments from 32 companies in 2025. Trend: 2023 $2,097 · 2024 $2,549 · 2025 $3,349
Food & beverage: $3,349
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $682 |
| Novartis Pharmaceuticals Corporation | 19 | $372 |
| AstraZeneca Pharmaceuticals LP | 10 | $312 |
| Daiichi Sankyo Inc. | 10 | $228 |
| Merck Sharp & Dohme LLC | 10 | $208 |
| SOBI, INC | 3 | $161 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $141 |
| Eisai Inc. | 6 | $128 |
| Aveo Pharmaceuticals, Inc. | 4 | $108 |
| Incyte Corporation | 5 | $103 |
Products named: RYBREVANT, Enhertu, KISQALI, DARZALEX, Vonjo, DATROWAY, Lenvima, KEYTRUDA.
Industry payments across FL — which companies pay providers there.
